Post‐inflammatory administration of N‐acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease

Post‐inflammatory administration of N‐acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease

Abstract Parkinson's disease (PD) is a complex, multifactorial neurodegenerative disease with a prevalence of 1% over the age of 55. Neuropathological hallmarks of PD include the loss of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of Lewy bodies that contain...

Full description

Bibliographic Details
Main Authors: Zeynep Bengisu Kaya, Elif Karakoc, Pamela J. McLean, Esen Saka, Pergin Atilla
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:FASEB BioAdvances
Subjects:
alpha‐synuclein (α‐syn)
apoptosis
N‐acetylcysteine (NAC)
neuroinflammation
Parkinson's disease
Online Access:https://doi.org/10.1096/fba.2022-00145

Internet

https://doi.org/10.1096/fba.2022-00145

Similar Items